Back to company

VarCT Diagnostics ApS: Financial statements 2020

CVR: 38733567

VarCT Diagnostics ApS (CVR 38733567) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,174,678 and a net result of DKK -760,968 compared with DKK -3,221,331 the year before. Equity amounted to DKK 8,742,104. The solvency ratio was 85.2%. The company had 3 employees in the financial year.

Gross Profit
1,174,678 kr.
Profit/Loss
-760,968 kr.
Equity
8,742,104 kr.
Total Assets
10,266,444 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-1.2 mio.-761 t.8.7 mio.3
2019--2 mio.-3.2 mio.9.5 mio.3
2018--472 t.-1.8 mio.12.7 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is VarCT Diagnostics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

VarCT Diagnostics ApS: The 2019 annual report is outMay 4, 2020

VarCT Diagnostics ApS has published its annual report for 2019. Gross profit came to DKK -2,020,592, and the net result was DKK -3,221,331.

Ulf Andreas Linderoth Norlin steps down as director of VarCT Diagnostics ApSMar 31, 2020

As of March 31, 2020, Ulf Andreas Linderoth Norlin has stepped down as director of VarCT Diagnostics ApS.

About VarCT Diagnostics ApS

VarCT Diagnostics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The company is owned by VAR2 PHARMACEUTICALS ApS and Sitour Management m.b.H.. The company has 4 employees. In 2025, the company reported a gross profit of DKK 176,862 and a net result of DKK -1,961,493 compared with DKK 779,245 the year before. Equity amounted to DKK 2,238,264.

Other financial years